Krilogy Financial LLC Tg Therapeutics, Inc. Transaction History

Krilogy Financial LLC

  • $1.35 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$3.44 - $5.76 $1,720 - $2,880
-500 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$5.15 - $14.0 $2,575 - $7,000
500 New
500 $3,000
Q2 2018

Aug 15, 2018
SELL
$12.5 - $15.0 $6,250 - $7,500
-500 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$8.7 - $16.8 $1,739 - $3,360
200 Added 66.67%
500 $7,000
Q2 2017

Aug 15, 2017
BUY
N/A
300
300 $3,000

Others Institutions Holding TGTX

# of Institutions
340
Shares Held
88.5M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.08B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email